These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 34356644)

  • 1. COVID-19 Vaccines and Thrombosis-Roadblock or Dead-End Street?
    Lundstrom K; Barh D; Uhal BD; Takayama K; Aljabali AAA; Abd El-Aziz TM; Lal A; Redwan EM; Adadi P; Chauhan G; Sherchan SP; Azad GK; Rezaei N; Serrano-Aroca Á; Bazan NG; Hassan SS; Panda PK; Pal Choudhury P; Pizzol D; Kandimalla R; Baetas-da-Cruz W; Mishra YK; Palu G; Brufsky AM; Tambuwala MM; Uversky VN
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways.
    Kircheis R
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia.
    Novak N; Tordesillas L; Cabanillas B
    Int Rev Immunol; 2022; 41(4):438-447. PubMed ID: 34251972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data.
    Cari L; Alhosseini MN; Fiore P; Pierno S; Pacor S; Bergamo A; Sava G; Nocentini G
    J Autoimmun; 2021 Dec; 125():102742. PubMed ID: 34710832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombosis with thrombocytopenia syndrome (TTS) following adenovirus vector COVID-19 vaccination in Canada.
    Procter TD; Ogasawara H; Spruin S; Wijayasri S; Abraham N; Blaser C; Hutchings K; Shaw A; Ogunnaike-Cooke S
    Vaccine; 2023 Nov; 41(46):6802-6809. PubMed ID: 37806804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential mechanisms of vaccine-induced thrombosis.
    Marietta M; Coluccio V; Luppi M
    Eur J Intern Med; 2022 Nov; 105():1-7. PubMed ID: 35953336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of vaccine-induced thrombotic thrombocytopenia in individuals who received COVID-19 adenoviral-vector-based vaccines.
    Elberry MH; Abdelgawad HAH; Hamdallah A; Abdella WS; Ahmed AS; Ghaith HS; Negida A
    J Thromb Thrombolysis; 2022 May; 53(4):798-823. PubMed ID: 35157188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis.
    Kim AY; Woo W; Yon DK; Lee SW; Yang JW; Kim JH; Park S; Koyanagi A; Kim MS; Lee S; Shin JI; Smith L
    Int J Infect Dis; 2022 Jun; 119():130-139. PubMed ID: 35339716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective review COVID-19 vaccine induced thrombotic thrombocytopenia and cerebral venous thrombosis-what can we learn from the immune response.
    Franceschi AM; Petrover DR; McMahon TM; Libman RB; Giliberto L; Clouston SAP; Castillo M; Kirsch C
    Clin Imaging; 2022 Oct; 90():63-70. PubMed ID: 35926315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil.
    Mouta Nunes de Oliveira P; Mendes-de-Almeida DP; Bertollo Gomes Porto V; Crespo Cordeiro C; Vitiello Teixeira G; Saraiva Pedro R; Roberto Gomes Takey P; Kegele Lignani L; Reis Xavier J; Cardoso Doria da Gama V; Amorim Filho L; Emoingt Furtado B; Santa Maria A; Dahrug Barros T; Neves Waite Freitas L; Dos Santos Pereira T; Lima Abreu D; Bernardes Ramos M; Gabe C; Arnold D; William Smith J; Nazy I; Lourdes de Sousa Maia M;
    Vaccine; 2022 Aug; 40(33):4788-4795. PubMed ID: 35779962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines.
    Hwang J; Lee SB; Lee SW; Lee MH; Koyanagi A; Jacob L; Tizaoui K; Yon DK; Shin JI; Smith L
    J Autoimmun; 2021 Aug; 122():102681. PubMed ID: 34139631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical studies do not reveal direct interactions between human PF4 and Ad26.COV2.S vaccine.
    van der Neut Kolfschoten M; Inganäs H; Perez-Peinado C; Calado da Silva Freire J; Melchers JM; van Dijk N; Przeradzka M; Kourkouta E; van Manen D; Vellinga J; Custers J; Bos R
    J Thromb Haemost; 2024 Apr; 22(4):1046-1055. PubMed ID: 38159648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-Stratified Risk of Cerebral Venous Sinus Thrombosis After SARS-CoV-2 Vaccination.
    Krzywicka K; van de Munckhof A; Sánchez van Kammen M; Heldner MR; Jood K; Lindgren E; Tatlisumak T; Putaala J; Kremer Hovinga JA; Middeldorp S; Levi MM; Cordonnier C; Arnold M; Zwinderman AH; Ferro JM; Coutinho JM; Aguiar de Sousa D
    Neurology; 2022 Feb; 98(7):e759-e768. PubMed ID: 34921101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic outcomes in patients in a large clinical enterprise following COVID-19 vaccination.
    Patterson WM; Greene BD; Tefera L; Bena J; Milinovich A; Mehta N; Chung MK; Kapadia S; Svensson LG; Cameron SJ
    J Thromb Thrombolysis; 2023 Apr; 55(3):426-431. PubMed ID: 36653575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of ChAdOx1 nCoV-19 and Ad26.COV2.S SARS-CoV-2 vector vaccines.
    Michalik S; Siegerist F; Palankar R; Franzke K; Schindler M; Reder A; Seifert U; Cammann C; Wesche J; Steil L; Hentschker C; Gesell-Salazar M; Reisinger E; Beer M; Endlich N; Greinacher A; Völker U
    Haematologica; 2022 Apr; 107(4):947-957. PubMed ID: 35045692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low clinical utility of testing for anti-platelet factor 4 in asymptomatic individuals after ChAdOx1 nCoV-19 vaccine.
    Barefah AS; Radhwi OO; Alamri SS; Alahwal HM; Denetiu I; Almohammadi AT; Bahashwan SM; Qari MH; Algaissi A; Alamer E; Alhazmi A; Abuzenadah AM; Nasraldeen WH; Alzahrani SH; Hashem AM
    Int J Lab Hematol; 2022 Apr; 44(2):424-429. PubMed ID: 34850575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review.
    Sharifian-Dorche M; Bahmanyar M; Sharifian-Dorche A; Mohammadi P; Nomovi M; Mowla A
    J Neurol Sci; 2021 Sep; 428():117607. PubMed ID: 34365148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Anionic Substances Binding to Platelet Factor 4 in Vaccine-Induced Thrombotic Thrombocytopenia of ChAdOx1-S Vaccine for SARS-CoV-2.
    Pang X; Liu H; He X; Ji T; Zhu Y; Cui Y
    Front Immunol; 2021; 12():782335. PubMed ID: 35095856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-severe acute respiratory syndrome coronavirus-2 adenoviral-vector vaccines trigger subclinical antiplatelet autoimmunity and increase of soluble platelet activation markers.
    Petito E; Colonna E; Falcinelli E; Mezzasoma AM; Cesari E; Giglio E; Fiordi T; Almerigogna F; Villa A; Gresele P
    Br J Haematol; 2022 Jul; 198(2):257-266. PubMed ID: 35577507
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 33.